Suppr超能文献

在人类心肌缺血预处理的信号转导途径中,蛋白激酶C-ε(PKC-ε)处于线粒体ATP敏感性钾通道(mitoKATP通道)的上游,而蛋白激酶C-α(PKC-α)处于其下游。

PKC-epsilon is upstream and PKC-alpha is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium.

作者信息

Hassouna Ashraf, Matata Bashir M, Galiñanes Manuel

机构信息

Integrative Human Cardiovascular Physiology and Cardiac Surgery Unit, Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester LE3 9QP, United Kingdom.

出版信息

Am J Physiol Cell Physiol. 2004 Nov;287(5):C1418-25. doi: 10.1152/ajpcell.00144.2004. Epub 2004 Aug 4.

Abstract

Protein kinase C (PKC) is involved in the process of ischemic preconditioning (IPC), although the precise mechanism is still a subject of debate. Using specific PKC inhibitors, we investigated which PKC isoforms were involved in IPC of the human atrial myocardium sections and to determine their temporal relationship to the opening of mitochondrial potassium-sensitive ATP (mitoKATP) channels. Right atrial muscles obtained from patients undergoing elective cardiac surgery were equilibrated and then randomized to receive any of the following protocols: aerobic control, 90-min simulated ischemia/120-min reoxygenation, IPC using 5-min simulated ischemia/5-min reoxygenation followed by 90-min simulated ischemia/120-min reoxygenation and finally, PKC inhibitors were added 10 min before and 10 min during IPC followed by 90-min simulated ischemia/120-min reoxygenation. The PKC isoforms inhibitors investigated were V1-2 peptide, GO-6976, rottlerin, and LY-333531 for PKC-epsilon, -alpha, -delta and -beta, respectively. To investigate the relation of PKC isoforms to mitoKATP channels, PKC inhibitors found to be involved in IPC were added 10 min before and 10 min during preconditioning by diazoxide followed by 90-min simulated ischemia/120-min reoxygenation in a second experiment. Creatine kinase leakage and methylthiazoletetrazolium cell viability were measured. Phosphorylation of PKC isoforms after activation of the sample by either diazoxide or IPC was detected by using Western blot analysis and then analyzed by using Scion image software. PKC-alpha and -epsilon inhibitors blocked IPC, whereas PKC-delta and -beta inhibitors did not. The protection elicited by diazoxide, believed to be via mitoKATP channels opening, was blocked by the inhibition of PKC-alpha but not -epsilon isoforms. In addition, diazoxide caused increased phosphorylation of PKC-alpha to the same extent as IPC but did not affect the phosphorylation of PKC-epsilon, a process believed to be critical in PKC activation. The results demonstrate that PKC-alpha and -epsilon are involved in IPC of the human myocardium with PKC-epsilon being upstream and PKC-alpha being downstream of mitoKATP channels.

摘要

蛋白激酶C(PKC)参与了缺血预处理(IPC)过程,尽管其确切机制仍存在争议。我们使用特异性PKC抑制剂,研究了哪些PKC亚型参与人心房肌切片的IPC,并确定它们与线粒体钾敏感性ATP(mitoKATP)通道开放的时间关系。从接受择期心脏手术的患者获取右心房肌,使其平衡后随机接受以下方案之一:有氧对照、90分钟模拟缺血/120分钟复氧、采用5分钟模拟缺血/5分钟复氧接着90分钟模拟缺血/120分钟复氧的IPC,最后,在IPC前10分钟和IPC期间10分钟添加PKC抑制剂,随后进行90分钟模拟缺血/120分钟复氧。所研究的PKC亚型抑制剂分别为针对PKC-ε、-α、-δ和-β的V1-2肽、GO-6976、rottlerin和LY-333531。为研究PKC亚型与mitoKATP通道的关系,在第二个实验中,在预处理前10分钟和预处理期间10分钟添加已发现参与IPC的PKC抑制剂,接着用二氮嗪进行预处理,随后进行90分钟模拟缺血/120分钟复氧。测定肌酸激酶泄漏和噻唑蓝细胞活力。通过蛋白质印迹分析检测经二氮嗪或IPC激活样品后PKC亚型的磷酸化情况,然后使用Scion图像软件进行分析。PKC-α和-ε抑制剂阻断IPC,而PKC-δ和-β抑制剂则无此作用。据信通过mitoKATP通道开放产生的二氮嗪诱导的保护作用,被PKC-α而非-ε亚型的抑制所阻断。此外,二氮嗪导致PKC-α的磷酸化增加程度与IPC相同,但不影响PKC-ε的磷酸化,这一过程被认为在PKC激活中至关重要。结果表明,PKC-α和-ε参与人心肌的IPC,其中PKC-ε位于mitoKATP通道上游,PKC-α位于其下游。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验